Diabetes patients who took a heart drug canadidate from Esperion Therapeutics, ETC 1002, found their so-called bad choleseterol, LDL-C, fall up to 43 percent, the company reported Monday.
A local organization is looking to help 100 low-income metro Detroiters with Type Two Diabetes
With the holidays here, it’s a perfect time to take stock of how we’re doing – health wise.
A new study finds that bacteria living in the intestines could be the key to finding an effective treatment for obesity.
RegeneRx Biopharmaceuticals Inc. (OTC Bulletin Board: RGRX) reported Wednesday that in a Michigan trial, researchers found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice.
A Wayne State University researcher is seeking to better understand what triggers the death of a type of cell that contributes to the onset of type 1 diabetes.
With a common goal of making health care better, safer, more cost effective and more equal, nearly 400 health researchers from across the University of Michigan and partner organizations have formed one of the nation’s largest research entities of its kind.
A Wayne State University researcher believes a protein that fails to reach the nucleus of retinal cells may play a role in causing eye disease in people with diabetes.
Aggressive efforts to lower blood pressure in people with diabetes are paying off – perhaps too well, according to a new study.
A study published online in the Journal of Biological Chemistry showed a new drug to treat diabetes being developed by Metabolic Solutions Development Co. LLC, MSDC-0602, improved insulin resistance and inflammation in obese mice.